Nourkrin® is committed to ensuring its recognition as a benchmark for excellence – not only by consumers, but also by scientists, dermatologists, cosmetologists and aestheticians worldwide.
Nourkrin® is based on more than 56 scientific studies and clinical papers as well as several consumer studies published in leading peer-review journals.
Nourkrin® has been tested in placebo, double-blind studies and shown to be side effect free.* This is in contrast to other pharmaceuticals, which may cause; scalp itching, dryness, scaling, flaking, irritation, burning and in extreme instances weight gain, swelling of the face, ankles, hands or stomach, difficulty breathing (especially when lying down), rapid heartbeat, chest pain and light headedness.**
Nourkrin® continues to partner with the world’s leading authorities on hair loss and hair thinning based on its clinically documented efficacy and safety standards.
Nourkrin® contains naturally based ingredients that have been scientifically documented to be safe and effective.
*2006, 2012, 2014, 2016 and 2018 studies published in leading international clinical journals.
**Studies about finastride: Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finastride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol .1998;39:578-89 & Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol.1999;40;930-7.
Do you need help, information, or just want to get in touch with us?
Contact us by phone or email:
Email: [email protected]
Visit these pages for further reading